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Introduction {#sec1}
============

During transcription, nascent RNA can hybridize with the DNA template strand, leaving the non-template DNA strand single stranded. These structures are called R-loops, and their persistent formation can cause deleterious effects on genome integrity, possibly due to the unpaired single-stranded DNA (ssDNA) ([@bib1], [@bib36], [@bib61]).

Even though R-loops have the potential to form over a large proportion of the genome, they are not a simple consequence of transcription. They occur at specific, conserved loci as a result of a complex interplay of the DNA sequence, transcription, topology, and chromatin environment ([@bib16]). At active mammalian protein-coding genes with unmethylated CpG-island promoters, R-loops are enriched over promoters and termination sites and enhance activation, and they are linked with histone marks of active transcription, such as mono- and tri-methylation of lysine 4 of histone H3 (H3K4me1/3) and H3 acetylation ([@bib33], [@bib34], [@bib59]). R-loops can act as transcriptional activators, but they can also induce transcriptional repression in different cell types and via various mechanisms ([@bib51], [@bib14], [@bib53], [@bib65], [@bib63]). This "dual" function of R-loops in activation or repression strongly suggests that R-loop formation can have different roles and mechanisms in different contexts.

The Polycomb group (PcG) proteins are major epigenetic regulators of transcriptional repression, and they are required to silence CpG-rich developmental regulator genes in embryonic stem cells (ESCs) and maintain patterns of gene expression established during cell commitment ([@bib48], [@bib23]). They assemble in two major multi-subunit complexes: Polycomb repressive complex 1 (PRC1) and PRC2. The catalytic components of PRC1 and PRC2 are RING1B and EZH2, respectively. RING1B monoubiquitinylates histone H2A in lysine 119 (H2Aub1), and EZH2 is a methyltransferase responsible for the di- and tri-methylation of H3 in lysine 27 (H3K27me2/3).

The mechanisms of Polycomb-mediated transcriptional repression are not fully understood. Despite their roles in repression, PcG-target genes in mouse embryonic stem cells (mESCs) display the active chromatin mark H3K4me3 ([@bib2], [@bib5], [@bib67]), RNA polymerase II (Pol II), and general transcription factors ([@bib11], [@bib22], [@bib18]). Pol II is detected over promoters and coding regions of PcG-repressed genes and exhibits serine5 phosphorylation (Ser5P) of its C-terminal domain (CTD), but not Ser2P or Ser7P, the latter being markers of productive transcriptional elongation ([@bib64], [@bib13], [@bib66]). Consistent with the presence of poised Pol II, low levels of nascent transcripts, but no significant amounts of mRNA, have been detected at some PcG targets ([@bib35], [@bib64], [@bib42], [@bib50]).

PcG recruitment to its target genes remains a complex pathway, as different mechanisms and factors have been invoked (reviewed in [@bib8]). For example, transcription itself plays a role, as gene silencing alone can promote PRC2 recruitment to CpG island promoters ([@bib46], [@bib55]). Recruitment of the canonical PRC1 to its targets is proposed to occur through a hierarchical process by prior deposition of H3K27me3 by PRC2 ([@bib68], [@bib10]). However, non-canonical PRC1 (which contains RYBP instead of CBX) can also be targeted to CpG islands by KDM2B lysine demethylase ([@bib28], [@bib38]) and recruit PRC2 via H2Aub1 ([@bib7], [@bib19]).

The presence of R-loops at PcG target genes has so far been explored in human ESCs, where a positive correlation was detected based on bioinformatic analysis ([@bib34]), and in differentiated mouse fibroblasts (NIH 3T3 line), where a negative correlation was reported ([@bib59]). It therefore remains unclear whether and how PcG-repression mechanisms are regulated by R-loops.

Here, we have used mESCs to explore the contribution of R-loops to PcG-repression mechanisms. We show that R-loops form at PcG targets and R-loop loss leads to deficient PcG recruitment and an altered poised state of Pol II, resulting in gene derepression. Genome-wide analyses show that R-loop formation is not a trivial consequence of low transcription levels and occurs only at a subset of PcG-repressed genes. Constitutive EZH2 (PRC2) knockout alone is not sufficient to affect R-loops or RING1B (PRC1) recruitment and does not lead to transcriptional derepression of R-loop-positive genes. In contrast R-loop removal in these conditions causes gene activation and reduced RING1B recruitment. Upon inhibition of EZH2 catalytic activity, R-loops and RING1B can repress PcG targets. Our results uncover an unanticipated interplay between R-loops and PRC1 recruitment that contributes to PcG repression.

Results {#sec2}
=======

R-Loops Form over PcG-Repressed Genes {#sec2.1}
-------------------------------------

To investigate whether R-loops play a role in the PcG-mediated transcriptional silencing, we measured their presence over a panel of PcG target genes using DNA-RNA immunoprecipitation (DIP or DRIP) analysis ([@bib62], [@bib33], [@bib34], [@bib63], [@bib59]) in mESCs. We chose five previously characterized genes, namely *Msx1*, *Math1*, *Nkx2.2*, *Nkx2.9*, and *Gata4*. These genes have well-annotated CpG island promoters, are GC-rich throughout their promoters and coding regions, and in mESCs are co-occupied by PRC1, PRC2, and poised Ser5P Pol II ([@bib64], [@bib13], [@bib29]). Native nuclear extracts were immunoprecipitated with the RNA-DNA-hybrid-specific antibody, S9.6 ([@bib9]), and the purified DNA was analyzed using primers positioned over the promoter (P) regions containing transcription start sites (TSSs) and within coding (C) regions at gene bodies. As a positive control, we used the highly expressed active gene *β-actin*, which forms R-loops over P and C regions ([@bib62], [@bib63]). As negative controls, we used the active gene *CyclinB1* that does not form R-loops ([@bib63]) and the gene *Myf5* that is neither expressed nor associated with PcG or Pol II in mESCs ([@bib64], [@bib13]). As expected, R-loops were enriched at *β-actin* but were not detected over *CyclinB1* or *Myf5*. Remarkably, R-loops were specifically enriched at both P and C regions at all five PcG-repressed genes ([Figure 1](#fig1){ref-type="fig"}A).Figure 1R-Loops Form over PcG-Repressed Genes, and Their Selective Removal Causes Transcriptional Activation(A) DRIP analysis using the RNA-DNA hybrid antibody S9.6 over Polycomb group (PcG)-repressed, active, and inactive genes. Primer regions to promoter (P) and coding (C) regions are indicated.(B) qRT-PCR analysis of total RNA performed on PcG-repressed and active genes with or without overexpression of RNase H1.(C) Detection of spliced transcripts upon RNase H1 overexpression on PcG-repressed, inactive, and active genes.Error bars represent SD; n = 3--4. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001.

To further assess R-loop presence and confirm their specificity, we overexpressed RNase H1 *in vivo*, an enzyme that specifically degrades RNA in RNA-DNA hybrids without cleaving the single-stranded RNA (ssRNA). We transfected mESCs for 48 h with a construct expressing GFP-tagged RNase H1 ([@bib15]) ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Importantly, mESCs retained expression of the pluripotency markers *Oct4* and *Nanog* upon transfection ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C). DRIP analysis following RNase H1 overexpression showed loss of R-loop signals over PcG-repressed and active genes ([Figure S1](#mmc1){ref-type="supplementary-material"}D), confirming that they are bona fide RNA-DNA hybrids.

We then sought to investigate the effects of transcription on R-loop formation and turnover at PcG-repressed genes as compared to active genes. We treated cells with 5,6-dichloro-1-β-D-ribofuranosyl-benzimidazole (DRB), a CDK9 inhibitor that interferes with transcriptional elongation by Pol II. R-loops were then measured over a PcG-repressed (*Nkx2.9*) and an active gene (*β-actin*) at specific time points after DRB treatment and post-wash conditions. As shown in [Figure S1](#mmc1){ref-type="supplementary-material"}E, R-loops rapidly decreased over *β-actin* after 10 min of DRB treatment and they reappeared 30 min post-wash. This argues for a dynamic resolution and formation of R-loops over active genes, as previously reported ([@bib59]). Strikingly, R-loops over *Nkx2.9* failed to resolve even after 3 h of DRB treatment, suggesting that R-loops over PcG-repressed genes are more stable than those formed over active genes and might therefore indicate a different function of R-loops in PcG targets.

Loss of R-Loops Leads to Derepression of PcG Target Genes {#sec2.2}
---------------------------------------------------------

Next, we investigated whether R-loop formation contributes to PcG-repression mechanisms by studying the transcriptional profiles of PcG-repressed and active genes upon R-loop removal. First, we assessed unprocessed (non-spliced and non-polyadenylated) transcripts by synthesizing cDNA from total RNA using reverse primers positioned over the first intron. Low levels of nascent transcripts could be detected over PcG-repressed genes ([Figure 1](#fig1){ref-type="fig"}B), as previously shown ([@bib35], [@bib64], [@bib42]). Notably, selective R-loop removal by RNase H1 overexpression led to an increase of nascent transcripts specifically over PcG-repressed genes, showing that R-loops contribute to their transcriptional silencing. In contrast, loss of R-loops over the active gene *β-actin* caused a mild decrease in the amount of nascent RNA ([Figure 1](#fig1){ref-type="fig"}B, right panel), consistent with the known transcriptional activator role of R-loops at some active genes ([@bib62], [@bib33], [@bib34], [@bib59]). The opposite effect of R-loop loss over PcG-repressed and active genes argues for a specific effect of RNase H1 overexpression on targeting the R-loop structure alone, rather than nascent RNAs, and a repressive role for R-loops at PcG targets. Moreover, it indicates distinct mechanisms of R-loop function at different gene groups.

We then tested whether R-loop removal is sufficient for transcript maturation and increased mRNA expression. To probe for poly-adenylated transcripts, we reverse-transcribed RNA using oligo-dT primers and amplified the cDNA using primers spanning the spliced junction between exon 1 and exon 2 for each gene ([Figure 1](#fig1){ref-type="fig"}C). We confirmed that no mRNA was detected over PcG-repressed genes in mESCs prior to R-loop removal, as expected. R-loop depletion led to the detection of spliced poly-adenylated transcripts from PcG-repressed genes, suggesting that R-loops are required for full PcG repression. Depletion of R-loops led to a mild depletion of spliced transcripts at the *β-actin* gene, whereas *CyclinB1* mRNA levels were unchanged.

R-Loops Co-occupy Chromatin with PcG Enzymes and Contribute to Their Recruitment {#sec2.3}
--------------------------------------------------------------------------------

To further explore the mechanisms by which R-loop formation at PcG targets promote transcriptional repression, we asked whether R-loops and PcG enzymes simultaneously co-occupy chromatin using sequential native chromatin immunoprecipitation (ChIP) ([Figure S2](#mmc1){ref-type="supplementary-material"}A). First, we performed single native ChIP analyses and confirmed the associations on chromatin of R-loops, EZH2, H3K27me3, and Ser5P Pol II are captured in native conditions ([Figures S2](#mmc1){ref-type="supplementary-material"}B--S2E).

Sequential native ChIP revealed that EZH2 co-occupies with R-loop chromatin, independent of the immunoprecipitation order ([Figures 2](#fig2){ref-type="fig"}A and 2B). No DNA was recovered over *β-actin*, as expected, confirming that there was no detectable carryover from the first ChIP with the S9.6 antibody. Negative control genes (*CyclinB1* and *Myf5*) showed no enrichment. We also confirmed co-association of EZH2 with Ser5P Pol II in native conditions ([Figure S2](#mmc1){ref-type="supplementary-material"}F), which was shown previously with cross-linked chromatin ([@bib13]). These results suggest that R-loops and PcG coincide on chromatin via indirect or direct interactions.Figure 2R-Loops Co-occupy with PcG Proteins on Chromatin and Contribute to Their Recruitment(A and B) Sequential native ChIP shows co-association of R-loops with EZH2 at PcG-repressed genes (A) and vice versa (B).(C and D) EZH2 (C) and RING1B (D) ChIP analyses on PcG-repressed and active *β-actin* genes upon RNase H1 overexpression. Regions C1/C2 correspond to C regions 300--400 and 700--800 bp downstream of the TSSs, respectively.Error bars represent SD; n = 3. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001.

Next, we tested whether recruitment of PcG enzymes was altered after RNase H1 overexpression. We confirmed the occupancy of EZH2 and RING1B at both P and C regions of our panel of PcG-repressed genes, but not at active genes in control mESCs. Upon R-loop resolution, EZH2 and especially RING1B occupancy was reduced at PcG-target genes ([Figures 2](#fig2){ref-type="fig"}C and 2D), although the total levels of these proteins were unaffected ([Figure S3](#mmc1){ref-type="supplementary-material"}A), suggesting that R-loops facilitate or stabilize the binding of PcG enzymes on their targets.

To test whether H3K27me3 and H2Aub1, the chromatin modifications instigated by PcG, are also affected upon R-loop removal, we performed ChIP analyses following RNase H1 overexpression ([Figures S3](#mmc1){ref-type="supplementary-material"}B and S3C). RNase H1 overexpression had a minimal effect on these chromatin marks, possibly due to the stability and low turnover levels of chromatin marks during the short window of RNaseH1 overexpression ([@bib45], [@bib30]). Interestingly, these conditions resulted in gene derepression upon loss of PRC occupancy without depletion of H3K27me3 and H2Aub1. Derepression may result from PRC functions that do not involve histone modifications and may therefore relate to other processes, such as chromatin condensation ([@bib27]).

R-Loops Contribute to PcG Recruitment Genome-wide {#sec2.4}
-------------------------------------------------

To explore more globally which PcG-repressed genes are regulated by R-loop formation, we tested which genes lose EZH2 after R-loop depletion by performing EZH2 ChIP sequencing (ChIP-seq) on mock-transfected cells and cells overexpressing RNase H1 ([Figures 3](#fig3){ref-type="fig"}A and 3B). Consistent with the single-gene ChIP results, the average distribution of EZH2 occupancy at PcG-repressed genes decreased upon R-loop resolution, confirming the dependency of PcG occupancy levels on R-loops ([Figure 3](#fig3){ref-type="fig"}A). This effect was not observed for silent genes that are not silenced through PcG repression (inactive genes) and was less pronounced for highly expressed active genes ([Figure 3](#fig3){ref-type="fig"}B). In contrast the recruitment of SUZ12, a non-catalytic subunit of PRC2, was almost unchanged over PcG-repressed genes upon R-loop resolution in our experimental setting ([Figure S4](#mmc1){ref-type="supplementary-material"}).Figure 3R-Loops Contribute to PcG Recruitment Genome-wide and Form at a Subset of PcG-Repressed Genes(A) Average distribution of EZH2 at PcG-repressed genes (n = 1,632) minus or plus RNaseH1 overexpression. The most (top 15%, n = 2,829) and least active genes (bottom 15% inactive, n = 2,829) are shown for comparison.(B) Boxplot with amount of signal for EZH2 minus or plus RNaseH1 in 1-kb windows centered on TSSs of Polycomb-repressed genes.(C) Proportion of PcG-repressed, active, and inactive genes that overlap with R-loops. Percentage of genes in each group that overlap with an R-loop peak but do not overlap with another R-loop-positive peak (dark color) or that overlap with other R-loop-positive peaks (light color) are shown.(D) GRO-seq RPKM data in R-loop-positive and negative Polycomb targets.(E) Number of PcG-repressed genes giving rise to R-loops and nascent RNA (GRO-seq, RPKM \> 0.1).(F--I) DRIP (F), RNA analysis (G and H), and EZH2 ChIP (I) on *Pax3*, *Hoxa7*, and *Mogat1* genes (n = 3).Error bars represent SD.

R-Loops Form at a Subset of PcG-Repressed Genes but Are Not an Inherent Feature of Low-Level Transcription {#sec2.5}
----------------------------------------------------------------------------------------------------------

To explore the extent to which R-loops form at PcG-repressed genes genome-wide, we re-analyzed published genome-wide DRIP-seq dataset of R-loops in mESCs ([@bib59]). R-loops were detected at 76% of active genes in mESCs and at a minor proportion of inactive genes ([Figure 3](#fig3){ref-type="fig"}C). R-loops were also detected at 409 PcG targets, raising the possibility that R-loop formation contributes to PcG repression only at a subset of genes. Next, we sought to investigate whether R-loop detection could simply result from low-level transcription detected at PcG-repressed genes. We mined a published global run-on (GRO-seq) dataset from mESCs ([@bib40]) and found that the R-loop-positive PcG targets are transcribed at levels similar to those of R-loop-negative PcG targets ([Figure 3](#fig3){ref-type="fig"}D). We then asked what proportion of PcG-repressed genes generating nascent RNA forms R-loops and found that 42% of them generate nascent RNA detectable with GRO-seq, and 29% of these genes form R-loops (196 genes, reads per kilobase of transcript per million mapped reads \[RPKM\] \> 0.1; [Figure 3](#fig3){ref-type="fig"}E). These results suggest that R-loops are not an inherent feature of low-level transcription.

We then investigated whether R-loops contribute to PcG repression at genes where they specifically form. We assessed transcriptional repression and PcG recruitment in single genes that do not show detectable R-loops in the published DRIP-seq data but exhibit nascent RNA detected either by GRO-seq or by alternative published RNA techniques. *Hoxa7* is a gene that shows nascent RNA in the GRO-seq, and *Pax3* is a gene with nascent RNA as detected previously by northern blot ([@bib42]). We chose *Mogat1* as a gene with no nascent RNA signal, based on the GRO-seq analysis and no detectable R-loop signal according to DRIP-seq. We employed DRIP experiments and found very low or absent R-loop signals over these genes compared to the R-loop-positive *Nkx2.9* ([Figure 3](#fig3){ref-type="fig"}F). We then confirmed the presence of nascent RNA for *Hoxa7* and *Pax3* genes, but unexpectedly, we also detected transcripts in *Mogat1*, which had no detectable GRO-seq signal ([Figure 3](#fig3){ref-type="fig"}G, gray bars). This implies that GRO-seq analysis, which is designed to detect products of actively elongating polymerases, can fail to detect low levels of nascent RNA in some PcG-repressed genes. Importantly, R-loop removal by RNase H1 overexpression did not affect either nascent or processed transcripts or the EZH2 recruitment over these R-loop-negative genes ([Figures 3](#fig3){ref-type="fig"}G--3I), unlike the deregulation observed at R-loop-positive genes ([Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). These results collectively highlight that R-loops contribute to PcG repression mechanisms only at genes where they specifically form. Furthermore, we found that the presence of low levels transcription is not sufficient to cause a gene to be R-loop positive. Representative examples of chromatin occupancy and transcription UCSC profiles at PcG-repressed genes with and without nascent RNA and R-loops are shown in [Figure S5](#mmc1){ref-type="supplementary-material"}.

Selective Removal of R-Loops Leads to an Activated Pol II State over PcG-Repressed Genes {#sec2.6}
----------------------------------------------------------------------------------------

To further dissect the mechanism of transcriptional activation mediated by loss of R-loops at PcG target genes ([Figures 1](#fig1){ref-type="fig"}B and 1C), we examined the effect of R-loop loss on Pol II activation. Pol II at PcG-repressed genes exists in a poised state, characterized by the exclusive presence of Ser5P ([@bib64], [@bib13], [@bib66]). In contrast, at active genes, Ser5P and Ser7P mark active gene promoters and are associated with transcriptional initiation and early elongation, whereas Ser2P is associated with productive elongation and termination ([@bib39], [@bib37]).

To determine whether the transcriptional activation of PcG target genes observed upon R-loop removal is linked to changes in CTD modification, we used the 8WG16 antibody, which recognizes non-phosphorylated Ser2 residues and shows minimal enrichment at PcG-repressed genes ([@bib64], [@bib12]). Interestingly, loss of R-loops after RNase H1 overexpression led to an increase of 8WG16 Pol II levels at PcG target genes ([Figure 4](#fig4){ref-type="fig"}A). However, *β-actin* showed decreased 8WG16 Pol II levels upon R-loop removal, consistent with the reduction in nascent and processed transcripts shown in [Figures 1](#fig1){ref-type="fig"}B and 1C. 8WG16 Pol II levels over the non-R-loop-forming *CyclinB1* gene remained unaffected. These results suggest that removal of R-loops at PcG target genes leads to a specific change in Pol II CTD modification that is now recognized by the 8WG16 antibody, an event that has been reported after loss of RING1B and H2Aub1 ([@bib64]).Figure 4Selective Removal of R-Loops Leads to an Activation of Pol II State over PcG-Repressed Genes(A--C) 8WG16 (A), Ser7P (B), and Ser5P (C) ChIP analyses upon RNase H1 overexpression on PcG-repressed and active genes. Error bars represent SD; n = 3. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001.

Since CTD modifications affect the detection of Pol II by 8WG16 epitope ([@bib70], [@bib64], [@bib12]), we examined additional CTD modifications in these conditions. PcG targets genes also exhibited an increase in the Ser7P Pol II levels ([Figure 4](#fig4){ref-type="fig"}B), which marks active genes, in line with gene derepression observed upon loss of R-loops ([Figures 1](#fig1){ref-type="fig"}B, 1C, and [4](#fig4){ref-type="fig"}A). Again, at the promoter of *β-actin*, but not *CyclinB1*, depletion of R-loops led to a decrease in Ser7P Pol II levels ([Figure 4](#fig4){ref-type="fig"}B, right panel).

R-loop depletion had no detectable effect on Ser5P occupancy levels ([Figure 4](#fig4){ref-type="fig"}C) over PcG target genes, implying that this CTD modification precedes R-loop formation and is not affected by decreased occupancy of PcG enzymes upon R-loop depletion. These data suggest that R-loops contribute to the transcriptional repression of PcG target genes via changes that affect not only PcG stability on chromatin but also Pol II activation.

Constitutive Loss of EZH2 Does Not Affect R-Loop Formation, RING1B Recruitment, or Repression of R-Loop-Positive PcG Genes {#sec2.7}
--------------------------------------------------------------------------------------------------------------------------

To investigate the role of PcG presence on R-loop formation and gene repression at PcG-repressed genes, we created constitutive knockout (KO) mESCs (parental mESC clone E14) for *Ezh2* by introducing three constitutive stop codons at the beginning of exon 7 using the CRISPR/Cas9 system. The loss of EZH2 protein levels and chromatin occupancy, as well as the loss of the H3K27me3 mark on chromatin, was confirmed over our model genes ([Figures S6](#mmc1){ref-type="supplementary-material"}A--S6C). Residual H3K27me3 was detected possibly due to the presence of EZH1, a homolog of EZH2 that can complement its activity ([@bib49], [@bib60]).

To investigate whether R-loop formation is affected upon PRC2 and H3K27me3 loss, we performed DRIP assays. First, we confirmed R-loop presence over PcG-repressed genes in the matched wild-type (WT) mESC clone. Importantly, R-loops were unaffected in *Ezh2* KO cells over R-loop-forming PcG-repressed genes, and control gene *β-actin* also remained unaffected, as expected. The negative control genes *Pax3*, *Mogat1*, *Hoxa7*, and *CyclinB1* showed no or very little enrichment, as expected ([Figure 5](#fig5){ref-type="fig"}A). This result is supported by the presence of Pol II Ser5P in the same conditions ([Figure S6](#mmc1){ref-type="supplementary-material"}D) and importantly reveals that R-loops form over PcG-repressed genes irrespectively of EZH2 presence.Figure 5Constitutive Loss of EZH2 Does Not Affect R-Loops, Gene Repression, and RING1B Recruitment(A) R-loop analysis in WT and *Ezh2* knockout (KO) mESCs.(B) qRT-PCR analysis of total RNA on indicated genes in WT and *Ezh2* KO mESCs.(C) RING1B Pol II ChIP analysis over PcG-repressed and active genes.Error bars represent SD; n = 3. ^∗^p \< 0.05, ^∗^p \< 0.01, ^∗∗^p \< 0.001.

We next tested whether KO of *Ezh2* causes transcriptional derepression of R-loop-positive PcG-repressed genes. Analysis of spliced transcripts revealed that R-loop-positive PcG-repressed genes do not show prevalent upregulation of their mature transcripts upon *Ezh2* KO. Interestingly, R-loop-negative PcG-repressed genes exhibited slight (*Mogat1* and *Hoxa7*) or higher (*Pax3*) derepression upon constitutive *Ezh2* loss ([Figure 5](#fig5){ref-type="fig"}B). *β-actin* showed an increase on mature transcripts upon loss of *Ezh2*, in line with studies showing upregulation of highly expressed active genes in *Eed* KO mESC, due to increase in H3K27me1 levels in these conditions ([@bib31]). Finally, 8WG16 Pol II levels were also unaffected over R-loop-positive PcG-repressed genes in *Ezh2* KO cells ([Figure S6](#mmc1){ref-type="supplementary-material"}E), consistent with no evident increase in spliced transcript levels.

The maintained repression of R-loop-positive PcG target genes upon constitutive EZH2 loss prompted us to investigate how PRC1 recruitment is affected upon R-loop formation. Strikingly, ChIP analysis revealed that RING1B levels at R-loop-positive genes were largely unaffected in the absence of EZH2, despite the reduction in H3K27me3 ([Figure 5](#fig5){ref-type="fig"}D). However, RING1B levels in R-loop-negative genes were reduced in *Ezh2* KO cells, consistent with the mild transcriptional derepression observed in these conditions. These results collectively predict that R-loops and RING1B presence could account, synergistically or independently, for the lack of derepression specifically over R-loop-positive PcG-repressed genes in the absence of EZH2 and upon reduced H3K27me3.

Chemical Inhibition of EZH2 Causes Gene Derepression without Loss of R-Loops {#sec2.8}
----------------------------------------------------------------------------

The findings that R-loops, RING1B, and gene repression were maintained upon *Ezh2* KO prompted us to interfere with both EZH1 and EZH2 methyltransferase activity. We used UNC1999 (UNC), an inhibitor that prevents H3K27me3 deposition at PcG-repressed genes without disrupting EZH1 and EZH2 chromatin binding ([@bib44], [@bib71], [@bib56]).

Upon UNC treatment, H3K27me3 levels were reduced ([Figure S7](#mmc1){ref-type="supplementary-material"}A), whereas EZH2 binding on chromatin remained unaffected ([Figure S7](#mmc1){ref-type="supplementary-material"}B). Notably, R-loops remained unaffected upon UNC treatment ([Figure 6](#fig6){ref-type="fig"}A), strongly suggesting that R-loops form upstream of both EZH1-2 activity and presence ([Figure 5](#fig5){ref-type="fig"}A). Again, Ser5P Pol II occupancy was also maintained over R-loop-positive PcG-repressed genes ([Figure S7](#mmc1){ref-type="supplementary-material"}C). UNC treatment and reduction of H3K27me3 led to derepression of R-loop-positive PcG target genes at the level of 8WG16 Pol II and spliced mRNA and was sufficient to deplete RING1B occupancy ([Figures S7](#mmc1){ref-type="supplementary-material"}D--S7F).Figure 6Catalytic Inhibition of EZH2 and Loss of R-loops Result in Enhanced Transcriptional Derepression and Reduced RING1B Recruitment(A) R-loop analysis upon UNC treatment.(B and C) 8WG16 (B) Pol II and RING1B (C) ChIP analyses on indicated genes with or without UNC treatment minus or plus RNase H1. (C) ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001.Error bars represent SD; n = 3.

R-Loops and RING1B Recruitment Both Contribute to the Transcriptional Repression of PcG Targets {#sec2.9}
-----------------------------------------------------------------------------------------------

We have showed that absence of EZH2 protein alone is not enough to alter the transcriptional status of R-loop-positive PcG-repressed genes, whereas interference either with R-loops or EZH1-2 catalytic activity causes their transcriptional derepression. To investigate whether R-loops and EZH2 activity act through parallel pathways or have synergistic effects on the silencing at PcG target genes, we combined R-loop removal and EZH2 inhibition and performed 8WG16 Pol II ChIP under the following conditions ([Figure 6](#fig6){ref-type="fig"}B): (1) untreated mock-transfected cells, where R-loops and EZH2 activity are both intact; (2) untreated cells overexpressing RNase H1, where R-loops are diminished and EZH2 and RING1B recruitment are reduced; (3) UNC-treated cells, where EZH2 still binds to chromatin but its catalytic activity is compromised and R-loops are still formed but RING1B is not recruited; and (4) UNC-treated cells overexpressing RNase H1, where both R-loops and EZH2 methyltransferase activity are deregulated. Remarkably, we observed a higher increase in 8WG16 Pol II over PcG-repressed genes in UNC-treated cells overexpressing RNase H1 (purple bars) than in cells with either R-loop depletion (red bars) or EZH2 inhibition (blue bars) alone, suggesting that both R-loops and EZH2 catalytic activity contribute to PcG repression. This effect was not observed at active genes ([Figure 6](#fig6){ref-type="fig"}B, bottom right panel).

We then tested whether the reduced recruitment of RING1B could account for the enhanced gene derepression observed in the combined conditions of R-loops loss and inhibition of PRC2 activity. After performing RING1B ChIP ([Figure 6](#fig6){ref-type="fig"}C) as above, we found reduced RING1B occupancy on chromatin upon R-loop resolution (red bars) and upon PRC2 inhibition (blue bars), as expected from our previous findings ([Figures 2](#fig2){ref-type="fig"}D and [S7](#mmc1){ref-type="supplementary-material"}F). Importantly, we observed a further significant decrease in RING1B recruitment over PcG target genes that form R-loops when PRC2 inhibition was combined with R-loop resolution (RNaseH1 + UNC; purple bars), as compared to UNC treatment alone (blue bars). This effect was specific to R-loop-positive genes, as R-loop-negative PcG-repressed genes showed no depletion in RING1B occupancy in combined conditions of R-loop resolution and UNC treatment. These results indicate that both R-loop formation and RING1B recruitment on chromatin are important to repress a subset of PcG targets that form R-loops and, importantly, highlight that RING1B recruitment and occupancy on chromatin can be also regulated by R-loop formation in the absence of PRC2 activity.

R-Loops Inhibit Productive Gene Expression Independently of EZH2 Occupancy on Chromatin {#sec2.10}
---------------------------------------------------------------------------------------

We next sought to investigate whether EZH2 (PRC2) occupancy on chromatin is important for gene repression in R-loop-forming PcG targets. We went back to the *Ezh2* KO system and tested whether removal of R-loops could induce gene activation in the absence of EZH2. We performed 8WG16 Pol II ChIP as a proxy for gene activation in the following conditions: (1) WT mock-transfected cells ([Figure 7](#fig7){ref-type="fig"}A, gray bars), (2) WT cells overexpressing RNase H1 (red bars), (3) *Ezh2* KO cells (orange bars), and (4) *Ezh2* KO cells overexpressing RNase H1 (green bars). Removal of R-loops led to an increase in 8WG16 Pol II levels in WT mESCs ([Figure 7](#fig7){ref-type="fig"}A, red bars). As observed before ([Figure 5](#fig5){ref-type="fig"}C), *Ezh2* KO cells do not exhibit signs of transcriptional activation. Interestingly, removal of R-loops in *Ezh2* KO cells leads to an increase in 8WG16 Pol II levels (green bars) over R-loop-positive PcG-repressed genes, indicative of gene activation. *Pax3*, *Mogat1*, and *Hoxa7*, PcG-repressed genes without R-loops, remained repressed. These results reveal that R-loop structures can act as transcriptional repressors in the PcG system independently of EZH2 (PRC2).Figure 7R-Loops and RING1B Recruitment Contribute to the Transcriptional Repression of PcG Targets in the Absence of EZH2(A) 8WG16 Pol II ChIP analysis on indicated genes in WT or *Ezh2* KO cells minus or plus RNase H1.(B) RING1B ChIP analysis in *Ezh2* KO cells minus or plus RNase H1.In (A) and (B), error bars represent SD; n = 3. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001.(C) The role of R-loops in the transcriptional repression of R-loop-positive PcG targets. The model is explained in the text. cPRC1, canonical PRC1.

Given that in *Ezh2* KO conditions RING1B was unaffected at R-loop-positive genes ([Figure 5](#fig5){ref-type="fig"}) and that RING1B recruitment on chromatin can also be regulated by R-loops ([Figure 6](#fig6){ref-type="fig"}C), we wondered whether the transcriptional change in *Ezh2* KO cells without R-loops could be due to changes in RING1B occupancy. We performed RING1B ChIP in *Ezh2* KO cells overexpressing RNase H1 and used WT and *Ezh2* KO cells as controls ([Figure 7](#fig7){ref-type="fig"}B). Remarkably, R-loop resolution by RNase H1 overexpression (green bars) led to a decrease in RING1B levels in all R-loop-positive PcG-repressed genes as compared to *Ezh2* KO (orange bars) and WT (gray bars) cells. *Pax3*, *Mogat1*, and *Hoxa7* genes exhibited no change in RING1B occupancy upon R-loop resolution in *Ezh2* KO cells. The above results suggested that R-loop formation is important for RING1B recruitment specifically at the subset of PcG-repressed genes that form R-loops.

Discussion {#sec3}
==========

Our results have collectively uncovered several unanticipated aspects of PcG-repression mechanisms at developmental regulator genes in mESCs, which consist of a synergistic interplay between R-loops and RING1B, the catalytic subunit of PRC1. We have identified a novel repression mechanism of PcG targets where R-loops are sufficient to repress, independently of EZH2 and of H3K27me3 and H2Aub1 chromatin marks.

Experiments targeting the catalytic activity of EZH1-2 allowed us to further dissect the role of RING1B in PcG regulation. EZH2 chemical inhibition resulted in reduction of RING1B and transcriptional activation. These results are in line with previous studies showing that the canonical PRC1 can be recruited to chromatin via prior H3K27me3 deposition mediated by PRC2 ([@bib68], [@bib10]). We now show that in the absence of PRC2 activity, RING1B can be recruited over PcG targets via the formation of R-loops. Interestingly R-loop profiles remained unaffected in *Ezh2* KO and upon chemical inhibition of EZH2, suggesting that R-loop formation may be a primary step in the repression pathway of R-loop-positive PcG targets.

We show a relationship between R-loops and RING1B, which is an intriguing new aspect of PcG regulation. PRC2 has been reported to bind RNA ([@bib20], [@bib41], [@bib21], [@bib4], [@bib69]), as was the CBX7 subunit of PRC1 ([@bib6], [@bib72], [@bib52], [@bib57]). However, there is no evidence for RING1B binding to RNA-containing structures, such as R-loops. R-loops can act as transcriptional repressors by slowing down Pol II ([@bib62]) and causing transcriptional blockage *in vitro* ([@bib3]). It is therefore possible that R-loops orchestrate the initial signal of transcriptional repression sensed by PRC1. R-loops have also been linked to chromatin compaction ([@bib58], [@bib16]) and could synergize with RING1B to compromise the elongation competence of Pol II ([@bib32], [@bib27], [@bib26]).

Our data reveal a novel class of PcG-repressed genes in mESCs ([Figure 7](#fig7){ref-type="fig"}C). At R-loop-positive PcG-repressed genes, R-loop formation interferes with the establishment of an elongating, active form of Pol II, which may initiate a defective state of gene expression. This effect can in turn assist RING1B to sense the transcriptional repression over these regions, synergize with EZH2, and actively impose silencing of PcG-repressed genes. In the absence of PRC2, R-loops can recruit or stabilize RING1B on chromatin and together impose transcriptional repression. Our results importantly highlight that PcG repression at developmental regulator genes in mESCs does not occur via a single mechanism but instead consists of different layers of repression, some of which are specific to the gene subset.

Previously, SUZ12 occupancy was shown to be increased upon loss of R-loops ([@bib17]). However, in our experimental setting, we did not observe a significant effect. SUZ12 occupancy genome-wide is almost unchanged upon R-loop resolution, as opposed to the reduction observed in EZH2 occupancy in the same conditions. It therefore remains an open question how different subunits are recruited and stabilized at PcG-repressed genes.

Our experimental strategy also highlighted differences between R-loop function over PcG-repressed and active genes ([Figure 7](#fig7){ref-type="fig"}C). Even though R-loops form over both sets of genes in mESCs, their lifetimes are different, and they display opposite roles in gene regulation at these two different genomic contexts of the same cell type. R-loops over PcG targets are less sensitive to transcription inhibition with DRB than over active genes, suggesting that their stability can depend on the gene context. R-loops act as transcriptional repressors in PcG-repressed genes but as transcriptional activators in active genes, the latter confirming previous observations in different cell types. Features such as the quality and fate of the nascent RNA involved in R-loop formation or the stability and length of R-loops in different loci could account for this binary effect. Future studies on the regulation and function of R-loops as "activators" and "repressors" will shed light into this intriguing duality.

Altogether, the current evidence supports functional associations among DNA, transcription, and chromatin over PcG-repressed genes. We now establish that this interplay can be regulated by the formation of R-loops and that RING1B may play a vital role in this pathway for transcriptional repression. These results provide a conceptual advance in our understanding of R-loop biology and PcG regulation.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Mouse monoclonal anti-RNA-DNA hybrids S9.6HybridomaN/ARabbit polyclonal anti-EZH2DiagenodepAb-039-050Rabbit monoclonal anti-RING1B (clone D22F2)Cell Signaling Technology5694; RRID: [AB_10705604](nif-antibody:AB_10705604){#interref130}Rabbit polyclonal anti-SUZ12Bethyl LaboratoriesA302-407A; RRID: [AB_1907290](nif-antibody:AB_1907290){#interref135}Rabbit polyclonal anti-H3K27me3Merck Millipore07-449; RRID: [AB_310624](nif-antibody:AB_310624){#interref140}Rabbit monoclonal anti-H2Aub1(clone D27C40)Cell Signaling Technology8240; RRID: [AB_10891618](nif-antibody:AB_10891618){#interref145}Mouse monoclonal anti-8WG16BioLegend920102; RRID: [AB_2565318](nif-antibody:AB_2565318){#interref150}Mouse monoclonal anti-Ser5P (clone CTD4H8)Merck Millipore05-623; RRID: [AB_309852](nif-antibody:AB_309852){#interref155}Mouse monoclonal anti-Ser7P (clone 4E12)Active Motif61087; RRID: [AB_2687452](nif-antibody:AB_2687452){#interref160}Rabbit polyclonal anti-OCT4Abcamab19857; RRID: [AB_445175](nif-antibody:AB_445175){#interref165}Rabbit polyclonal anti-NANOGAbcamab21624; RRID: [AB_446437](nif-antibody:AB_446437){#interref170}Mouse monoclonal γ-tubulin (clone GTU-88)Sigma-AldrichT5326; RRID: [AB_532292](nif-antibody:AB_532292){#interref175}**Chemicals, Peptides, and Recombinant Proteins**UNC1999 inhibitorSigma-AldrichSML07785,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB)Sigma-AldrichD1916**Critical Commercial Assays**Chromatrap kit for Native ChIPChromatrap500238Multiplex Oligos for IlluminaNew England BiolabsE7335S and E7500SRNA XP beads for library purificationBeckman CoulterA63987High Sensitivity DNA analysis kitAgilent5067-4626NEBNext Ultra II DNA library kit for IlluminaNew England BiolabsE7645SSuperScript III First-Strand Synthesis SystemThermo Fisher Scientific18080051**Deposited Data**Raw sequencing data EZH2 and SUZ12 −/+over-RNase H1 ChIP-seqThis studyGEO: [GSE118115](ncbi-geo:GSE118115){#intref0010}Re-analyzed DRIP-seq data[@bib59]GEO: [GSM1720620](ncbi-geo:GSM1720620){#intref0015}Re-analyzed GRO-seq data[@bib40]GEO: [GSE48895](ncbi-geo:GSE48895){#intref0020}Re-analyzed H3K27me3 ChIP-seq data[@bib50]GEO: [GSM307619](ncbi-geo:GSM307619){#intref0025}Re-analyzed H2Aub1 ChIP-seq data[@bib13]GEO: [GSM850471](ncbi-geo:GSM850471){#intref0030}Re-analyzed EZH2 ChIP-seq data[@bib46]GEO: [GSM327668](ncbi-geo:GSM327668){#intref0035}Re-analyzed RING1B ChIP-seq data[@bib46]GEO: [GSM327669](ncbi-geo:GSM327669){#intref0040}Re-analyzed RNAPII-S5p ChIP-seq data[@bib13]GEO: [GSM850467](ncbi-geo:GSM850467){#intref0045}Re-analyzed RNAPII-8WG16 ChIP-seq data[@bib13]GEO: [GSM850469](ncbi-geo:GSM850469){#intref0050}Re-analyzed RNAPII-S7p ChIP-seq data[@bib13]GEO: [GSM850468](ncbi-geo:GSM850468){#intref0055}Re-analyzed RNAPII-S2p ChIP-seq data[@bib13]GEO: [GSM850470](ncbi-geo:GSM850470){#intref0060}Re-analyzed mRNA-seq data[@bib13]GEO: [GSM850476](ncbi-geo:GSM850476){#intref0065}Raw image data (Western blots)Mendeley<https://doi.org/10.17632/55f4vg9ww4.1>**Experimental Models: Cell Lines**mESC clone 46C (WT)Pombo labN/AmESC clone E14 (WT)Voigt labN/AmESC *Ezh2* KOThis studyN/A**Oligonucleotides**See [Table S1](#mmc1){ref-type="supplementary-material"}N/A**Software and Algorithms**Bowtie v.2.0.5[@bib47]N/ATopHat v.2.0.8[@bib43]N/AR<https://www.r-project.org>N/A

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Konstantina Skourti-Stathaki (<kskourti@staffmail.ed.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

Mouse ESC cells (46C, E14 and *Ezh2* KO) were grown on 0.1% gelatin-coated surfaces in GMEM BHK21 supplemented with 10% Fetal Calf Serum (FCS), 2mM L-glutamine, 1% MEM non-essential amino acids (NEAA), 1mM sodium pyruvate (GIBCO, Invitrogen), 50 μM 2-mercaptoethanol, 100 U/ml of human recombinant leukemia inhibitory factor (LIF, Chemicon, Millipore).

Method Details {#sec4.4}
--------------

### Cell treatments {#sec4.4.1}

Transfections with the GFP-RNase H1 plasmid into 46C, E14 and *Ezh2* KO mESCs were carried out as described previously ([@bib62], [@bib63]). Cells were harvested 48 h post-transfection. Treatment with 3 μΜ of UNC-1999 inhibitor (Sigma) was maintained for 72 hr and performed as described previously ([@bib44], [@bib71], [@bib56]). Control cells were treated with DMSO. Treatment with 80 μM of DRB inhibitor (Sigma) was performed as previously described ([@bib59]).

### Generation of Ezh2 KO cell line {#sec4.4.2}

E14 mESCs were transfected with pX458 plasmid ([@bib54]) encoding a guide RNA targeting exon 7 of the mouse *Ezh2* gene (20-bp target sequence CAGCAGGAAATTTCCGAGGT), along with a single-stranded DNA oligonucleotide for homology-directed repair to introduce three consecutive stop codons at the 5′ end of exon 7 (resulting sequence ATtAAtAAgCTTGatCACCTC, mutated bases in lower case). After fluorescence-based sorting for GFP-positive transfected single cells, single cell colonies were expanded, genotyped, and analyzed for EZH2 expression by western blot. Correct genotypes were confirmed by Sanger sequencing on PCR-amplified genomic material.

### DIP/DRIP analysis {#sec4.4.3}

DNA immuno-precipitation (DIP/DRIP) analysis was carried out largely as described previously ([@bib62]) and was based on cross-linked ChIP analysis (see below) with some modifications. In essence, DIP analysis was performed without a cross-linking step, following the ChIP protocol with some modifications. After the nuclear lysis reaction, extracts were incubated with 30 μg of proteinase K (Roche) at 55°C genomic DNA was isolated. Following sonication, DIP analysis was carried out using antibody, recognizing RNA-DNA hybrids, purified from S9.6 hybridoma cell lines ([@bib9]). Washes and elution were carried out as in conventional ChIP analysis (see below). The immuno-precipitated, non-precipitated, and input DNAs were used as templates for qPCR. The PCR mixture contained QuantiTect SYBR green PCR master mix, 2 μL of the template DNA and primers from the [Table S1](#mmc1){ref-type="supplementary-material"}. Final concentrations are shown as a % of the input value.

### RNA analysis {#sec4.4.4}

Cells were washed with PBS and were harvested by adding 1 mL of Trizol reagent (ThermoFisher Scientific). RNA was then isolated following the manufacturer's instructions, DNase I treated for a total of 2 h (turbo DNA-*free*, Ambion kit), and reverse transcribed with SuperScript III Reverse Transcriptase (ThermoFisher Scientific), either using oligo-dT primer or a gene-specific primer from the [Table S1](#mmc1){ref-type="supplementary-material"}, following the manufacturers' instructions.

### Cross-linked ChIP analysis {#sec4.4.5}

Cells were fixed for 15 mins by addition of 36.5% methanol-stabilized formaldehyde solution, cross-linking was quenched by adding 1.32 mL of 1 M glycine and cells were washed and harvested in ice-cold PBS. Cells were lysed with cell lysis buffer (50mM Tris-HCl pH8, 2mM EDTA pH8, 0.1% NP40, 10% glycerol) and incubated for 10 mins on ice. The lysed cells were then centrifuged to pellet nuclei. The nuclear pellets were resuspended in Nuclear lysis buffer (1% SDS, 10mM EDTA, 50mM Tris-HCl pH8) and fragmented by sonication. 35-50 μg of chromatin was pre-cleared with A/G magnetic beads (ThermoFisher Scientific) for 1 h at 4°C and then immuno-precipitated in IP dilution buffer (0.5%NP40, 200mM NaCl, 50mM Tris-HCl pH8) with 3.5-5 μg of antibody overnight. Washes were performed using low salt wash buffer (0.1% SDS, 0.5% NP40, 2mM EDTA, 20mM Tris-HCl pH8, 150mM NaCl), high salt wash buffer (0.1% SDS, 0.5% NP40, 2mM EDTA, 20mM Tris pH8, 500mM NaCl) and LiCl wash buffer (250mM LiCl, 0.5% NP40, 0.5% Na-deoxycholate, 1mM EDTA, 20mM Tris-HCl pH8) and eluted samples were reverse crosslinked for 4 hr to O/N hr at 65°C with 0.3 M NaCl and 3 μg/ml RNase A (Roche). Proteinase K treatment was performed for 2 hr at 45°C with 10 mM EDTA, 40 mM Tris-HCl pH 6.5 and 20 μg proteinase K. The chromatin was purified. The immuno-precipitated, non-precipitated, and input DNAs were used as templates for qPCR. The PCR mixture contained QuantiTect SYBR green PCR master mix, 2 μl of the template DNA and primers from the [Table S1](#mmc1){ref-type="supplementary-material"}. Final concentrations are shown as a % of the input value.

The following antibodies were used for ChIP: anti-EZH2 (pAb-039-050, Diagenode), anti-RING1B (clone D22F2, 5694, Cell Signaling), anti-H3K27me3 (07-449, Millipore), anti-H2Aub1 (clone D27C4, 8240, Cell Signaling), anti-8WG16 (920102, Biolegend), anti-Ser5P (clone CTD4H8, 05-623, Millipore) and anti-Ser7P (clone 4E12, 61087, Active Motif).

### ChIP-sequencing {#sec4.4.6}

ChIP protocol as described above was followed. The chromatin was purified using the MinElute PCR Purification kit (Cat. 28004, QIAGEN) and DNA concentration for library preparation was determined using Qubit fluorometric quantitation (ThermoFisher Scientific). Libraries were prepared from 8ng of DNA using the NEBNext Ultra II DNA library kit for Illumina (Cat. E7645S, NEB), following the manufacturers' instructions. Size selection was performed prior to PCR amplification using RNA clean XP beads (Cat. A63987, Beckman Coulter). Adaptors, PCR amplification and Index Primers were used to multiplex libraries (Multiplex oligos for Illlumina, Cat. E7335S and E7500S, NEB). Libraries were purified using RNA clean XP beads (Cat. A63987, Beckman Coulter) and library size was assessed before high-throughput sequencing by Bioanalyzer (Agilent) using the High Sensitivity DNA analysis kit (Cat. 5067-4626, Agilent). ChIP-seq libraries were sequenced paired-end on an Illumina HiSeq2500 sequencer at the Wellcome Trust Sanger Institute (Cambridge, UK). The following antibodies were used for ChIP-seq: anti-EZH2 (pAb-039-050, Diagenode) and anti-SUZ12 (A302-407A, Bethyl Laboratories).

### Native ChIP analysis {#sec4.4.7}

Nascent ChIP analysis was carried out using the Chromatrap kit for native ChIP (Chromatrap) following the manufacturers' protocol. All buffers used were provided. In brief, non-crosslinked cells were harvested in ice-cold PBS and lysed in Hypotonic buffer. Nuclei were pelleted by nuclear separation. Chromatin was sheared using enzymatic shearing cocktail and smaller fragments were collected via centrifugation. Dialysis was performed O/N to remove unwanted contaminants and to obtain larger chromatin fragments. Small and large chromatin fragments were combined and immunoprecipitation was performed in a 35 μg:14 μg chromatin: antibody ratio, for all antibodies used in this study. Antibodies used were the same as indicated above.

Washes and elution was performed using the columns provided. Chromatin samples were digested with Proteinase K and DNA purification was performed. The immuno-precipitated, non-precipitated, and input DNAs were used as templates for qPCR. The PCR mixture contained QuantiTect SYBR green PCR master mix, 2 μl of the template DNA and primers from the [Table S1](#mmc1){ref-type="supplementary-material"}. Final concentrations are shown as a % of the input value.

### Sequential native ChIP analysis {#sec4.4.8}

Native chromatin was prepared and the first immunoprecipitation was performed as in single native ChIP using the Chromatrap kit (see above). After the elution of native chromatin in 50 μL total volume, the eluate was diluted 10-fold to obtain final concentration of 0.1% SDS for optimal second immunoprecipitation. The second immunoprecipitation, washes, and elution were then carried out following the single native ChIP protocol (see above). A no-antibody control was included in the second round of immunoprecipitation as a negative control, to test for contamination of antibody remaining from the first immunoprecipitation. All antibodies used are indicated above.

### Western blot analysis {#sec4.4.9}

Cells were washed with ice-cold PBS. Cell pellets were resuspended in RIPA lysis buffer (50mM Tris pH7.5, 150mM NaCl, 150mM NP40, 0.5% Na-deoxycholate, 0.1% SDS, 10% glycerol). Cell lysis was performed for 20 mins on ice. Protein lysate was recovered by centrifugation and protein-containing supernatant was kept. Protein concentration was measured by Bradford assay (BIORAD). Western blotting was performed on 40 μg of total 46C mES cell protein extracts with antibodies raised against EZH2 (Diagenode), RING1B (Cell Signaling), OCT4 (Abcam), NANOG (Abcam) and γ-tubulin (Sigma), all at 1:1000 dilutions. Western blotting was performed with ECL kit (PerkinElmer).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

### Bio-informatic analyses {#sec4.5.1}

#### Mapping and processing of ChIP-seq datasets with *Drosophila melanogaster* Spike-Ins {#sec4.5.1.1}

ChIP-seq reads from paired-end sequencing (Illumina HiSeq 2500, 2x75bp) were aligned to the mouse genome mm9 and *Drosophila melanogaster* genome dm6 with Bowtie v2.0.5 ([@bib47]), with default parameters. Duplicated reads (i.e., identical reads, aligned to the same genomic location) occurring more often than a threshold were removed. The threshold is computed for each dataset as the 95th percentile of the frequency distribution of reads.

To allow comparison between datasets, the amount of signal was normalized using *Drosophila* Spike-Ins as described in Active Motive catalog and as described in [@bib25]. Briefly, the number of reads mapped to mouse was divided for the number of reads mapped to *Drosophila* in that dataset, then multiplied by 10^6^ for convenience.

Average ChIP-seq profiles were generated as previously ([@bib13]), by plotting the average coverage in non-overlapping windows of 10 bp, across genomic windows centered on the TSS and the TES. Boxplots were produced using R.

### R-loop genome-wide analysis {#sec4.5.2}

R-loop DRIP peaks in E14 ESCs from [@bib59] were downloaded from GEO repository (GSM1720620). Gene list and classification were obtained from [@bib13]. Genes were classified as positive for R-loops if a R-loop peak overlapped the gene (defined as the genomic region 1kb before the gene's TSS to 1kb after the gene's TES). Positive genes that overlapped with other R-loop positive genes in the window described above were classified as 'uncertain due to proximity'.

#### Features of R-loop positive and R-loop negative PRC repressed genes {#sec4.5.2.1}

PRC repressed genes from [@bib13] were divided into positive and negative for R-loops as described above. Most active genes (top 15%, n = 2829) or least active (bottom 15%, n = 2829) were defined as in [@bib24] using FPKM values, among genes negative for Polycomb marks (H3K27me3 and H2Aub1) from [@bib13].

Nascent RNA RPKMs (reads per kilobase per million of reads mapped) were calculated based on the bedgraph files from [@bib40] (untreated ES cells downloaded from GEO: [GSE48895](ncbi-geo:GSE48895){#intref0085}). RPKM values represent the number of reads mapped in the sense of the gene from TSS to TES per kilobase (TSS to TES length) per million of reads mapped. Genes whose expression was \>0.1 RPKM were considered positive for nascent RNA. As a technical note, GRO-seq relies on an *in vitro* transcription step by active transcribing polymerases which for Polycomb-repressed could be a technical challenge and therefore it is possible that not all nascent RNAs generated from Polycomb-repressed genes can be captured.

#### Single gene profiles {#sec4.5.2.2}

Single gene profiles are taken from UCSC genome browser (<http://genome.ucsc.edu>), using the following datasets:•R-loop peaks, from [@bib59], downloaded from GEO (GSM1720620);•R-loops from the same paper, raw data downloaded from GEO and remapped as described below;•GRO-seq for plus and minus strands from [@bib40], downloaded from GEO (GSE48895) as bedgraph files;•H3K27me3, from [@bib50] (GSM307619), raw data downloaded from GEO and remapped as described below;•H2AK119ub1, from [@bib13] (GSM850471), raw data downloaded from GEO and remapped as described below;•EZH2 and RING1B from [@bib46] (GSM327668 and [GSM327669](ncbi-geo:GSM327669){#intref0095}), raw data downloaded from GEO and remapped as described below;•RNAPII-S5p, RNAPII-8WG16, RNAPII-S7p and RNAPII-S2p from Brookes et al., 2012 (GSM850467, [GSM850469](ncbi-geo:GSM850469){#intref0100}, [GSM850468](ncbi-geo:GSM850468){#intref0105}, [GSM850470](ncbi-geo:GSM850470){#intref0110}), raw data downloaded from GEO and remapped as described below;•mRNA-seq from [@bib13] (GSM850476), raw data downloaded from GEO and remapped as described below.

ChIP-seq sequenced reads were aligned to the mouse genome mm9 with Bowtie v2.0.5 ([@bib47]), with default parameters. Duplicated reads (i.e identical reads, aligned to the same genomic location) occurring more often than a threshold were removed. The threshold is computed for each dataset as the 95th percentile of the frequency distribution of reads. mRNA-seq reads were mapped to the mouse genome mm9 and the UCSC mm9 Known Gene GTF annotation file using TopHat ([@bib43]) v2.0.8, default parameters.

### p values and Statistical analysis {#sec4.5.3}

Statistical tests in all figures, except [Figure 3](#fig3){ref-type="fig"}D, were performed using two-tailed, unpaired Student's distribution t test, where ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. p value in [Figure 3](#fig3){ref-type="fig"}D is calculated with Wilcoxon rank-sum test. All numbers of independent biological repeats are indicated for each figure and panel in the corresponding Figure Legend.

Data and Software Availability {#sec4.6}
------------------------------

Datasets produced in this study have been deposited in GEO in the following link: <https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118115>. Original images of western blot assays are available at Mendeley Data <https://doi.org/10.17632/55f4vg9ww4.1>.
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